Please Note: This trial is no longer enrolling new participants
Outcomes and Predictors of Survival in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) Following Progression After CAR T-Cell Therapy and CD20xCD3 Bispecific Antibody Treatment
| Protocol No. | CTO-IRB-25-08-8026 | Scope | National |
|---|---|---|---|
| Principal Investigator | Varun Mittal | Treatment Type | Retrospective |
| Age Group | Adult | Phase | NA |
